The purpose of this nonclinical laboratory study was to establish the repeat - dose tolerance of COMPOUND_XXX , a potent inhibitor of the Bcr - Abl tyrosine kinases , foreseen primarily in the treatment of chronic myeloid leukemias ( CML ) , when administered to rats for 2 weeks .
The purpose of this nonclinical laboratory study was to establish the repeat - dose tolerance of COMPOUND_XXX , a potent inhibitor of the Bcr - Abl tyrosine kinases , foreseen primarily in the treatment of chronic myeloid leukemias ( CML ) , when administered to rats for 2 weeks .
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O